Epidemiologic patterns of diarrheal disease in Argentina: Estimation of rotavirus disease burden

Pediatric Infectious Disease Journal

Volumn 21, Issue 9, 2002, Pages 843-850

  Gomez, Jorge A ^a   Sordo, Maria E ^a   Gentile, Angela ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Argentina; Diarrhea; Epidemiology; Gastroenteritis; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

AGE; ARGENTINA; ARTICLE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DIARRHEA; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HOSPITAL; ROTAVIRUS; SEASONAL VARIATION; VIRUS INFECTION;

AGE FACTORS; ARGENTINA; CHILD; CHILD, PRESCHOOL; DEATH CERTIFICATES; DIARRHEA; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; ROTAVIRUS INFECTIONS; SEASONS;

EID: 0036377880     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200209000-00012     Document Type: Article

References (29)

1. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 1992;70:705-14.
2. World Bank. World Bank Development Report 1993: Investing in Health. New York: Oxford University Press, 1993.
3. Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. Health Econ 2000;9:19-35.
4. Gurwith M, Wenman W, Gurwith D, Brunton J, Feltham S, Greenberg H. Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis 1983;147:685-92.
5. Gomez JA, Bercovich J, Biscotti E, et al. diarrea por rotavirus: estudio prospectivo de 49 familias del Partido de Avellaneda, Pcia. de Buenos Aires. Arch Argent Pediatria 1987;85:139-49.
6. Grinstein S, Gomez JA, Bercovich JA, Biscotti EL. Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children. Am J Epidemiol 1989;130:300-8.
7. Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR. First rotavirus vaccine licensed: is there really a need? Acta Paediatr Suppl 1999;88:2-8.
8. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status andfuture priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207-22.
9. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
10. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 1983;309:72-6.
11. Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis 1993;168:282-7.
12. Ward RL, Bernstein DI. Protection against rotavirus disease after natural rotavirus infection: US Rotavirus Vaccine Efficacy Group. J Infect Dis 1994;169:900-4.
13. Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live, attenuated, human rotavirus vaccine 8:9-12 in infants: a randomised placebo-controlled trial. Lancet 1999;354:287-90.
14. Clark HF, Offit PA, Ellis RW, et al. WC3 reassortant vaccines in children. Arch Virol Suppl 1996;12:187-98.
15. Clements-Mann ML, Makhene MK, Mrukowicz J, et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine 1999;17:2715-25.
16. Gomez JA, Nates S, De Castagnaro NR, Espul C, Borsa A, Glass RI. Anticipating rotavirus vaccines: review of epidemiologic studies of rotavirus diarrhea in Argentina. Panam J Pub Health 1998;3:69-78.
17. Bok K, Castagnaro N, Borsa A, et al. Surveillance for rotavirus in Argentina. J Med Virol 2001;65:190-8.
18. Bok K, Castagnaro NC, Diaz NE, et al. Rotavirus laboratory network: results after one year of observation (in Spanish). Rev Argent Microbiol 1999;31:1-12.
19. Gonzalez FS, Sordo ME, Rowensztein G, et al. Rotavirus diarrhea: impact in a pediatric hospital of Buenos Aires. Medicina (B Aires) 1999;59:321-6.
20. O'Ryan M, Pérez-Schael I, Mamani N, et al. Rotavirus associated outpatient visits and hospitalizations in South America: a prospective study in three large sentinel hospitals. Pediatr Infect Dis J 2001;20:685-93.
21. Cohen J. Medicine: rethinking a vaccine's risk. Science 2001; 293:1576-7.
22. Dirección de Epidemiología. Boletín epidemiológico semanal de patologías de vigilancia intensificada. Buenos Aires: Ministerio de Salud, 1994-1998.
23. Dirección de Estadística e Información de la Salud. Egresos de establecimientos oficiales por diagnosticos: total pais y division politico territorial. Buenos Aires: Ministerio de Salud, 1995-1998.
24. Dirección de Estadística e Información de la Salud. Agrupamiento de causas de mortalidad por jurisdicción de residencia, edad y sexo, Argentina, 1995 y 1996. Buenos Aires: Ministerio de Salud, 1998.
25. PAHO. Argentina: health in the Americas. Washington, DC: Panamerican Health Organization, 1998:18-39.
26. INDEC. Proyecciones de la población por provincia, segun sexo y grupos de edad; 1990-2010. Analisis demografico. Buenos Aires: Instituto Nacional de Estadisticas y Censos, 1995.
27. Abramson JH, Gahlinger PM. Computer Programs For Epidemiologists (PEPI), Version 4.0. Salt Lake City: Sagebrush Press, 2001.
28. Sordo ME, Rocatagliata GM, Dastugue MG, Murno JR, Lapaco de Tripoli M. Oral rehydration experience in 266 cases (in Spanish). Rev Hosp Niños Buenos Aires 1986;28:4-17.
29. Gutiérrez G, Tapia-Conyer R, Guiscafré H, Reyes H, Martínez H, Kumate J. Impact of oral rehydration and selected public health interventions on reduction of mortality from childhood diarrheal disease in Mexico. Bull World Health Organ 1996;74:189-97.